Prospective Study
Copyright ©The Author(s) 2025.
World J Virol. Jun 25, 2025; 14(2): 106479
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.106479
Table 1 Patients’ characteristics, mean ± SD
Variables
Non-responder
Responder
P value
Gender (male/female)30/4540/600.242
Age (years)51.55 ± 6.9949.4 ± 7.00.071
Alanine aminotransaminase (U/L)70.2 ± 21.060.0± 15.80.017
Aspartate aminotransaminase (U/L)68.9 ± 16.954.6 ± 14.90.004
ALP (U/L)123.9 ± 32.898.9 ± 20.90.018
Bilirubin (mg/dL)1.15 ± 0.280.96 ± 0.350.011
Albumin (g/dL)3.35 ± 0.393.88 ± 0.510.0001
Creatinine (mg/dL)0.87 ± 0.180.81 ± 0.160.082
α-fetoprotein (ng/mL)3.62 ± 1.193.59 ± 0.880.769
INR1.25 ± 0.151.13 ± 0.060.069
Hemoglobin (g/dL)11.88 ± 2.6013.10 ± 1.340.071
Platelets (× 109/L)155.9 ± 43.9191.2 ± 35.90.0001
White blood cells (× 109/L)4.91 ± 1.675.49 ± 1.370.0620
Red blood cells (× 1012/L)5.33 ± 1.884.98 ± 1.170.0840
APRI1.20 ± 0.310.78 ± 0.220.0001
FIB-43.11 ± 1.011.94 ± 0.560.0001
Table 2 Diagnostic performances of the index compared to each marker alone
Categories
AUC (95%CI)
Sensitivity (%)
Specificity (%)
PPV (%)
NPV (%)
Accuracy (%)
PIIINP ≥ 19.5 μg/L0.684 (0.59-0.78)69.35051.068.558.3
HA ≥ 82 μg/L0.766 (0.66-0.87)70.76963.175.869.71
PIIINP × HA > 18400.809 (0.72-0.90)74.77468.379.674.3
Table 3 Correlation between the index and each marker alone with factors related to treatment failure
VariableHA × PIIINP
HA
PIIINP
r
P value
r
P value
r
P value
ALT (U/L)0.1820.0910.1270.0960.1210.210
AST (U/L)0.2120.089a0.1140.1330.1500.182
ALP (U/L)0.1910.0590.1120.2140.0710.261
Albumin (g/dL)-0.260.021a-0.200.044a-0.2010.043a
Bilirubin (mg/dL)0.1940.0620.1360.0790.0990.223
Platelets (× 109/L)-0.190.058-0.130.083-0.1230.158
FIB-40.2160.022a0.1860.041a0.1850.041a
APRI0.2230.019a0.1880.041a0.1810.041a